<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141659759795000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201902028%26RESULT%3d1%26SIGN%3dT6kO80FVHmyd0obZBV8R0iicBPc%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902028&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902028&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902028&amp;v=MDY2OTZxQnRHRnJDVVI3cWZadVptRnlqbVZML0FQVFhNWmJHNEg5ak1yWTlIYklRS0RIODR2UjRUNmo1NE8zenE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#4" data-title="&lt;b&gt;1&lt;/b&gt; Th&lt;b&gt;1细胞与&lt;/b&gt;AS "><b>1</b> Th<b>1细胞与</b>AS</a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#7" data-title="&lt;b&gt;2&lt;/b&gt; Th&lt;b&gt;2细胞与&lt;/b&gt;AS "><b>2</b> Th<b>2细胞与</b>AS</a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#10" data-title="&lt;b&gt;3&lt;/b&gt; Th&lt;b&gt;17细胞与&lt;/b&gt;AS "><b>3</b> Th<b>17细胞与</b>AS</a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#14" data-title="&lt;b&gt;4&lt;/b&gt; Treg&lt;b&gt;细胞与&lt;/b&gt;AS "><b>4</b> Treg<b>细胞与</b>AS</a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#17" data-title="&lt;b&gt;5 展 望&lt;/b&gt; "><b>5 展 望</b></a><i></i></p>
                                                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="56">


                                    <a id="bibliography_1" title="Ren HY, Khera A, de Lemos JA, et al.Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population[J].Am Heart J, 2017, 191:55-61." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES3CD895DED957AD96C9F281DD8E906BFA&amp;v=MDcyMzBpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4THU0d0tBPU5pZk9mYkRMYXRuRnF2c3dFT0lLQ3cxTnhoQmc0MGwvUUg2VzJCcEFjTEtTTjh6dUNPTnZGUw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        Ren HY, Khera A, de Lemos JA, et al.Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population[J].Am Heart J, 2017, 191:55-61.
                                    </a>
                                </li>
                                <li id="58">


                                    <a id="bibliography_2" title="Libby P, Lichtman AH, Hansson GK.Immune effector mechanisms implicated in atherosclerosis:from mice to humans[J].Immunity, 2013, 38 (6) :1092-1104." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13080100041009&amp;v=MjUwMzRuTXJvOUZaTzhPREh3d29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhaG89TmlmT2ZiSzdIdA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        Libby P, Lichtman AH, Hansson GK.Immune effector mechanisms implicated in atherosclerosis:from mice to humans[J].Immunity, 2013, 38 (6) :1092-1104.
                                    </a>
                                </li>
                                <li id="60">


                                    <a id="bibliography_3" title="GisterA, Hansson GK.The immunology of atherosclerosis[J].Nat Rev Nephrol, 2017, 13 (6) :368-380." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=The immunology of atherosclerosis">
                                        <b>[3]</b>
                                        GisterA, Hansson GK.The immunology of atherosclerosis[J].Nat Rev Nephrol, 2017, 13 (6) :368-380.
                                    </a>
                                </li>
                                <li id="62">


                                    <a id="bibliography_4" title="Taleb S.Inflammation in atherosclerosis[J].Arch Cardiovasc Dis, 2016, 109 (12) :708-715." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Inflammation in atherosclerosis">
                                        <b>[4]</b>
                                        Taleb S.Inflammation in atherosclerosis[J].Arch Cardiovasc Dis, 2016, 109 (12) :708-715.
                                    </a>
                                </li>
                                <li id="64">


                                    <a id="bibliography_5" title="Li Y, Liu X, Duan W, et al.Batf3-dependent CD8α+Dendritic Cells Aggravates Atherosclerosis via Th1 Cell Induction and Enhanced CCL5Expression in Plaque Macrophages[J].EBio Med, 2017, 18:188-198." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES4430C9E8D488B13CE014ED7A20F5AAB5&amp;v=MTQ2OTdmT0dRbGZCckxVMDV0Qmh4THU0d0tBPU5pZk9mYmU4SGRHL3B2cE5FTzhIQkE0NHpHVm02ajU1UFF2bDNSQTFEN2ZsTk1pYUNPTnZGU2lXV3I3SklGcG1hQnVIWQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        Li Y, Liu X, Duan W, et al.Batf3-dependent CD8α+Dendritic Cells Aggravates Atherosclerosis via Th1 Cell Induction and Enhanced CCL5Expression in Plaque Macrophages[J].EBio Med, 2017, 18:188-198.
                                    </a>
                                </li>
                                <li id="66">


                                    <a id="bibliography_6" title="Zhao Y, Dai XY, Zhou Z, et al.Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice[J].Acta Pharmacol Sin, 2016, 37 (2) :196-203." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Leucine supplementation via drinking water reduces atherosclerotic lesions in apo E nullmice">
                                        <b>[6]</b>
                                        Zhao Y, Dai XY, Zhou Z, et al.Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice[J].Acta Pharmacol Sin, 2016, 37 (2) :196-203.
                                    </a>
                                </li>
                                <li id="68">


                                    <a id="bibliography_7" title="Zhong Y, Tang H, Wang X, et al.Intranasal immunization with heat shock protein 60induces CD4 (+) CD25 (+) GARP (+) and type 1regulatory T cells and inhibits early atherosclerosis[J].Clin Exp Immunol, 2016, 183 (3) :452-468." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+and type 1 regulatory T cells and inhibits early atherosclerosis">
                                        <b>[7]</b>
                                        Zhong Y, Tang H, Wang X, et al.Intranasal immunization with heat shock protein 60induces CD4 (+) CD25 (+) GARP (+) and type 1regulatory T cells and inhibits early atherosclerosis[J].Clin Exp Immunol, 2016, 183 (3) :452-468.
                                    </a>
                                </li>
                                <li id="70">


                                    <a id="bibliography_8" title="Benagiano M, Gerosa M, Romagnoli J, et al.β2Glycoprotein IRecognition Drives Th1 Inflammation in Atheroselerotic Plagues of Patients with Primay Antiphospholipid Syndrome[J].J Immunol, 2017, 198 (7) :2640-2648." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJRS&amp;filename=SJRS8885904F7BC70082CFF04CF63CEF7232&amp;v=MjIxOTd4UmduRWw5VEF5VXFoRkdETVNUUjdtZENPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMdTR3S0E9TmlmWmZidXdGdFRGcjRzelk1bDhDM3c1eA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        Benagiano M, Gerosa M, Romagnoli J, et al.β2Glycoprotein IRecognition Drives Th1 Inflammation in Atheroselerotic Plagues of Patients with Primay Antiphospholipid Syndrome[J].J Immunol, 2017, 198 (7) :2640-2648.
                                    </a>
                                </li>
                                <li id="72">


                                    <a id="bibliography_9" title="Ji Q, Zeng Q, Huang Y, et al.Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome[J].Mediators Inflamm, 2014, 2014:165742." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJHD&amp;filename=SJHD14031900000667&amp;v=MzE2MjRhcks4SHRMTnBvOUZaT3NQQ25vK29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhaG89TmlmRA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        Ji Q, Zeng Q, Huang Y, et al.Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome[J].Mediators Inflamm, 2014, 2014:165742.
                                    </a>
                                </li>
                                <li id="74">


                                    <a id="bibliography_10" title="Antoniades C, Bakogiannis C, Tousoulis D, et al.TheCD40/CD40ligand system:linking inflammation with atherothrombosis[J].J Am Coll Cardiol, 2009, 54 (8) :669-677." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100340083&amp;v=MDcwMDM9TmlmT2ZiSzdIdERPcm85RlorOFBESFE2b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFobw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        Antoniades C, Bakogiannis C, Tousoulis D, et al.TheCD40/CD40ligand system:linking inflammation with atherothrombosis[J].J Am Coll Cardiol, 2009, 54 (8) :669-677.
                                    </a>
                                </li>
                                <li id="76">


                                    <a id="bibliography_11" title="Meng K, Zeng Q, Lu Q, et al.Valsartan Attenuates Atherosclerosis via Upregulating the Th2Immune Response in Prolonged Angiotensin II-Treated ApoE (-/-) Mice[J].Mol Med, 2015, 21:143-153." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Valsartan Attenuates Atherosclerosis via Upregulating the Th2Immune Response in Prolonged Angiotensin II-Treated ApoE (-/-)Mice">
                                        <b>[11]</b>
                                        Meng K, Zeng Q, Lu Q, et al.Valsartan Attenuates Atherosclerosis via Upregulating the Th2Immune Response in Prolonged Angiotensin II-Treated ApoE (-/-) Mice[J].Mol Med, 2015, 21:143-153.
                                    </a>
                                </li>
                                <li id="78">


                                    <a id="bibliography_12" title="Zhao XN, Li YN, Wang YT.Interleukin-4regulates macrophage polarization via the MAPK signaling pathway to protect against atherosclerosis[J].Genet Mol Res, 2016, 15 (1) ." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Interleukin-4 regulates macrophage polarization via the MAPK signaling pathway to protect against atherosclerosis">
                                        <b>[12]</b>
                                        Zhao XN, Li YN, Wang YT.Interleukin-4regulates macrophage polarization via the MAPK signaling pathway to protect against atherosclerosis[J].Genet Mol Res, 2016, 15 (1) .
                                    </a>
                                </li>
                                <li id="80">


                                    <a id="bibliography_13" title="Silveira A, McLeod O, Strawbridge RJ, et al.Plasma IL-5concentration and subclinicalcarotid atherosclerosis[J].Atherosclerosis, 2015, 239 (1) :125-130." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14123100002962&amp;v=MTczMjRGaW5sVXJmSUlGMFRhaG89TmlmT2ZiSzhIOVBQcm85RlpPc05CWG83b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        Silveira A, McLeod O, Strawbridge RJ, et al.Plasma IL-5concentration and subclinicalcarotid atherosclerosis[J].Atherosclerosis, 2015, 239 (1) :125-130.
                                    </a>
                                </li>
                                <li id="82">


                                    <a id="bibliography_14" title="IBC 50KCAD Consortium.Large-scale gene-centric analysis identifies novel variants for coronary artery disease[J].PLoSGenet, 2011, 7 (9) :e1002260." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Large-scale gene-centric analysis identifies novel variants for coronary artery disease">
                                        <b>[14]</b>
                                        IBC 50KCAD Consortium.Large-scale gene-centric analysis identifies novel variants for coronary artery disease[J].PLoSGenet, 2011, 7 (9) :e1002260.
                                    </a>
                                </li>
                                <li id="84">


                                    <a id="bibliography_15" title="Tsiantoulas D, Bot I, Ozsvar-Kozma M, et al.Increased Plasma IgE Accelerate Atherosclerosis in Secreted IgM Deficiency[J].Circ Res, 2017, 120 (1) :78-84." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK9E1FD91CEEF5FB9708824A0059313AC4&amp;v=MjMzNzJaYnJOSDZlNHBvNDJFWjU1Q1FwTHhoRVQ0amQvVEE3aXJCYzhlck9YTk1tYkNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMdTR3S0E9TmlmYw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        Tsiantoulas D, Bot I, Ozsvar-Kozma M, et al.Increased Plasma IgE Accelerate Atherosclerosis in Secreted IgM Deficiency[J].Circ Res, 2017, 120 (1) :78-84.
                                    </a>
                                </li>
                                <li id="86">


                                    <a id="bibliography_16" title="Ishigami T, Abe K, Aoki I, et al.Anti-interleukin-5and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5levels[J].FASEB J, 2013, 27 (9) :3437-3445." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Anti-interleukin-5and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5levels">
                                        <b>[16]</b>
                                        Ishigami T, Abe K, Aoki I, et al.Anti-interleukin-5and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5levels[J].FASEB J, 2013, 27 (9) :3437-3445.
                                    </a>
                                </li>
                                <li id="88">


                                    <a id="bibliography_17" title="Cardilo-Reis L, Gruber S, Schreier SM, et al.Interleukin-13protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype[J].EMBO Mol Med, 2012, 4 (10) :1072-1086." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD121010003256&amp;v=MTA5NzdIN24zeEU5ZmJ2bktyaWZaZVp2RnludFU3L0xKMTRjTmlmY2FySzZIOUhOcjQ5Rlora0tDaE04enhVU21EZDlT&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[17]</b>
                                        Cardilo-Reis L, Gruber S, Schreier SM, et al.Interleukin-13protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype[J].EMBO Mol Med, 2012, 4 (10) :1072-1086.
                                    </a>
                                </li>
                                <li id="90">


                                    <a id="bibliography_18" title="Miller AM, Xu D, Asquith DL, et al.IL-33reduces the development of atherosclerosis[J].J Exp Med, 2008, 205 (2) :339-346." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=IL-33 reduces the development of atherosclerosis">
                                        <b>[18]</b>
                                        Miller AM, Xu D, Asquith DL, et al.IL-33reduces the development of atherosclerosis[J].J Exp Med, 2008, 205 (2) :339-346.
                                    </a>
                                </li>
                                <li id="92">


                                    <a id="bibliography_19" title="Lim H, Kim YU, Sun H, et al.Proatherogenic conditions promote autoimmune T helper 17cell responses in vivo[J].Immunity, 2014, 40 (1) :153-165." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14032300128011&amp;v=MjQ2MzNla0hESDA0b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFobz1OaWZPZmJLOEh0TE9ySTlGWg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[19]</b>
                                        Lim H, Kim YU, Sun H, et al.Proatherogenic conditions promote autoimmune T helper 17cell responses in vivo[J].Immunity, 2014, 40 (1) :153-165.
                                    </a>
                                </li>
                                <li id="94">


                                    <a id="bibliography_20" title="Nanke Y, Yago T, Kotake S.The Role of Th17Cells in the Pathogenesis of Behcet&#39;s Disease[J].J Clin Med, 2017, 6 (7) .pii:E74." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=The role of Th17 cells in the pathogenesis of Behcet&amp;#39;&amp;#39;s disease">
                                        <b>[20]</b>
                                        Nanke Y, Yago T, Kotake S.The Role of Th17Cells in the Pathogenesis of Behcet&#39;s Disease[J].J Clin Med, 2017, 6 (7) .pii:E74.
                                    </a>
                                </li>
                                <li id="96">


                                    <a id="bibliography_21" title="Danzaki K, Matsui Y, Ikesue M, et al.Interleukin-17Adeficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Biol, 2012, 32 (2) :273-280." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12121700002251&amp;v=MjM5NjVUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFobz1OaWZjWmJLNkg5UE5xSTlGWk9zTkRuazRvQk1UNg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[21]</b>
                                        Danzaki K, Matsui Y, Ikesue M, et al.Interleukin-17Adeficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Biol, 2012, 32 (2) :273-280.
                                    </a>
                                </li>
                                <li id="98">


                                    <a id="bibliography_22" title="Usui F, Kimura H, Ohshiro T, et al.Interleukin-17deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice[J].Biochem Biophys Res Commun, 2012, 420 (1) :72-77." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011701949455&amp;v=MTIzMTd0RE5xSTlFYmU4R0NIazhvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYWhvPU5pZk9mYks3SA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[22]</b>
                                        Usui F, Kimura H, Ohshiro T, et al.Interleukin-17deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice[J].Biochem Biophys Res Commun, 2012, 420 (1) :72-77.
                                    </a>
                                </li>
                                <li id="100">


                                    <a id="bibliography_23" title="Madhur MS, Funt SA, Li L, et al.Role of interleukin 17in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice[J].Arterioscler Thromb Vasc Biol, 2011, 31 (7) :1565-1572." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12121700002011&amp;v=MTIyMzFJSUYwVGFobz1OaWZjWmJLNkg5UE5xSTlGWk9zTkRIMDRvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[23]</b>
                                        Madhur MS, Funt SA, Li L, et al.Role of interleukin 17in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice[J].Arterioscler Thromb Vasc Biol, 2011, 31 (7) :1565-1572.
                                    </a>
                                </li>
                                <li id="102">


                                    <a id="bibliography_24" title="Taleb S, Tedgui A, Mallat Z.IL-17and Th17cells in atherosclerosis:subtle and contextual roles[J].Arterioscler Thromb Vasc Biol, 2015, 35 (2) :258-264." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=IL-17and Th17cells in atherosclerosis:subtle and contextual roles">
                                        <b>[24]</b>
                                        Taleb S, Tedgui A, Mallat Z.IL-17and Th17cells in atherosclerosis:subtle and contextual roles[J].Arterioscler Thromb Vasc Biol, 2015, 35 (2) :258-264.
                                    </a>
                                </li>
                                <li id="104">


                                    <a id="bibliography_25" title="Akhavanpoor M, Akhavanpoor H, Gleissner CA, et al.The Two Faces of Interleukin-17A in Atherosclerosis[J].Curr Drug Targets, 2017, 18 (7) :863-873." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SBAD&amp;filename=SBADDC07D90CC860753F328E8CEBE02ABD94&amp;v=MDE0NjNoeEx1NHdLQT1OaS9LYXNmTEh0YTRwbzgyRitNSkRIczh6R0FRNkRjSVFBeVgzbWMxZThQbU1iT2JDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[25]</b>
                                        Akhavanpoor M, Akhavanpoor H, Gleissner CA, et al.The Two Faces of Interleukin-17A in Atherosclerosis[J].Curr Drug Targets, 2017, 18 (7) :863-873.
                                    </a>
                                </li>
                                <li id="106">


                                    <a id="bibliography_26" title="Ladeiras-Lopes R, Koenig W.Interleukin-17in atherosclerosis:Still a long road ahead[J].Int J Cardiol, 2016, 202:932." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES3F0D8E345FFB41F05894BCFC850D631D&amp;v=MDU1ODZ1SFlmT0dRbGZCckxVMDV0Qmh4THU0d0tBPU5pZk9mYkRPSHFYRTJveEJZWjE1Zm5nNHVSWVc0alo1T2d5VTN4b3dlY2FTUnJ2ckNPTnZGU2lXV3I3SklGcG1hQg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[26]</b>
                                        Ladeiras-Lopes R, Koenig W.Interleukin-17in atherosclerosis:Still a long road ahead[J].Int J Cardiol, 2016, 202:932.
                                    </a>
                                </li>
                                <li id="108">


                                    <a id="bibliography_27" title="Simon T, Taleb S, Danchin N, et al.Circulating levels of interleukin-17and cardiovascular outcomes in patients with acute myocardial infarction[J].Eur Heart J, 2013, 34 (8) :570-577." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Circulating levels of interleukin-17 and car-diovascular outcomes in patients with acute myocardial infarction">
                                        <b>[27]</b>
                                        Simon T, Taleb S, Danchin N, et al.Circulating levels of interleukin-17and cardiovascular outcomes in patients with acute myocardial infarction[J].Eur Heart J, 2013, 34 (8) :570-577.
                                    </a>
                                </li>
                                <li id="110">


                                    <a id="bibliography_28" title="GisterA, Robertson AK, Andersson J, et al.Transforming growth factor-βsignaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway[J].Sci Transl Med, 2013, 5 (196) :196ra100." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway">
                                        <b>[28]</b>
                                        GisterA, Robertson AK, Andersson J, et al.Transforming growth factor-βsignaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway[J].Sci Transl Med, 2013, 5 (196) :196ra100.
                                    </a>
                                </li>
                                <li id="112">


                                    <a id="bibliography_29" title="Kyaw T, Toh BH, Bobik A.Foxp3+CD4+Regulatory T-Cell Subtypes and Atherosclerosis[J].Circ Res, 2016, 119 (11) :1151-1153." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK062582406F0F1875FB373C964D169D52&amp;v=MTU3OTFKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeEx1NHdLQT1OaWZjWmJPK0hOVEVyWXRGWXAwUGVuMHh5Qk5sbUR4NlN3enJxaFpCZUxTZE1iK2RDT052RlNpV1dyNw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[29]</b>
                                        Kyaw T, Toh BH, Bobik A.Foxp3+CD4+Regulatory T-Cell Subtypes and Atherosclerosis[J].Circ Res, 2016, 119 (11) :1151-1153.
                                    </a>
                                </li>
                                <li id="114">


                                    <a id="bibliography_30" title="Ji Q, Meng K, Yu K, et al.Exogenous interleukin 37ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice[J].Sci Rep, 2017, 7 (1) :3310." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in Apo E-deficient mice">
                                        <b>[30]</b>
                                        Ji Q, Meng K, Yu K, et al.Exogenous interleukin 37ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice[J].Sci Rep, 2017, 7 (1) :3310.
                                    </a>
                                </li>
                                <li id="116">


                                    <a id="bibliography_31" title="Klingenberg R, Gerdes N, Badeau RM, et al.Depletion of FOXP3+regulatory T cells promotes hypercholesterolemia and atherosclerosis[J].J Clin Invest, 2013, 123 (3) :1323-1334." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SPQD&amp;filename=SPQD130423021866&amp;v=MjE0MzQvTEoxNGNOajNhYXJLN0h0WE9ySTlIWmVNSkNoTTh6eFVTbURkOVNIN24zeEU5ZmJ2bktyaWZaZVp2RnludFU3&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[31]</b>
                                        Klingenberg R, Gerdes N, Badeau RM, et al.Depletion of FOXP3+regulatory T cells promotes hypercholesterolemia and atherosclerosis[J].J Clin Invest, 2013, 123 (3) :1323-1334.
                                    </a>
                                </li>
                                <li id="118">


                                    <a id="bibliography_32" title="Dinh TN, Kyaw TS, Kanellakis P, et al.Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibodycomplexes expands CD4+CD25+Foxp3+regulatory T cells and attenuates development and progression of atherosclerosis[J].Circulation, 2012, 126 (10) :1256-1266." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK120927000313&amp;v=MjYxNTBFOWZidm5LcmlmWmVadkZ5bnRVNy9MSjE0Y05pZmNaYks2SHRqT3FJOUZaT2dPRHhNOHp4VVNtRGQ5U0g3bjN4&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[32]</b>
                                        Dinh TN, Kyaw TS, Kanellakis P, et al.Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibodycomplexes expands CD4+CD25+Foxp3+regulatory T cells and attenuates development and progression of atherosclerosis[J].Circulation, 2012, 126 (10) :1256-1266.
                                    </a>
                                </li>
                                <li id="120">


                                    <a id="bibliography_33" title="Kita T, Yamashita T, Sasaki N, et al.Regression of atherosclerosis with anti-CD3antibody via augmenting a regulatory T-cell response in mice[J].Cardiovasc Res, 2014, 102 (1) :107-117." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice">
                                        <b>[33]</b>
                                        Kita T, Yamashita T, Sasaki N, et al.Regression of atherosclerosis with anti-CD3antibody via augmenting a regulatory T-cell response in mice[J].Cardiovasc Res, 2014, 102 (1) :107-117.
                                    </a>
                                </li>
                                <li id="122">


                                    <a id="bibliography_34" title="Wigren M, Kolbus D, Dunr P, et al.Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine[J].J Intern Med, 2011, 269 (5) :546-556." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine">
                                        <b>[34]</b>
                                        Wigren M, Kolbus D, Dunr P, et al.Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine[J].J Intern Med, 2011, 269 (5) :546-556.
                                    </a>
                                </li>
                                <li id="124">


                                    <a id="bibliography_35" title="Huo Y, Chu Y, Guo L, et al.Cortisol is associated with low frequency of interleukin 10-producing B cells in patients with atherosclerosis[J].Cell Biochem Funct, 2017, 35 (3) :178-183." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD0C43B1A2190363AB5543D0E78D774658&amp;v=MzA5NTNyV1FRNytYQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeEx1NHdLQT1OaWZjYXJQTEd0SytydjVIWmVJUEQzbzZ2bVFXN3p0K1BIK1hxeHBCZg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[35]</b>
                                        Huo Y, Chu Y, Guo L, et al.Cortisol is associated with low frequency of interleukin 10-producing B cells in patients with atherosclerosis[J].Cell Biochem Funct, 2017, 35 (3) :178-183.
                                    </a>
                                </li>
                                <li id="126">


                                    <a id="bibliography_36" title="Tian YL, Wang LJ, Wu Y, et al.Pioglitazone ameliorates atherosclerosis in apoE knockout mice through transforming growth factor-β/Smad signaling and adaptive T cell immunity[J].Nan Fang Yi Ke Da Xue Xue Bao, 2017, 37 (8) :1003-1009." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=DYJD201708002&amp;v=MTkzMjc0SDliTXA0OUZab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkwvQUlUVEJhckc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[36]</b>
                                        Tian YL, Wang LJ, Wu Y, et al.Pioglitazone ameliorates atherosclerosis in apoE knockout mice through transforming growth factor-β/Smad signaling and adaptive T cell immunity[J].Nan Fang Yi Ke Da Xue Xue Bao, 2017, 37 (8) :1003-1009.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(02),241-244 DOI:10.3969/j.issn.1008-0074.2019.02.28            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm">T<b>淋巴细胞在动脉粥样硬化中的研究进展</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BC%A0%E8%83%9C%E7%94%B7&amp;code=38430647&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">张胜男</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%8E%8B%E7%BE%8E%E7%90%AA&amp;code=38430646&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">王美琪</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%90%B4%E5%81%A5&amp;code=22930624&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">吴健</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E4%BA%8E%E6%B3%A2&amp;code=22904382&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">于波</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%AD%99%E5%8B%87&amp;code=22869719&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">孙勇</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%93%88%E5%B0%94%E6%BB%A8%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%BA%8C%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=1044277&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">哈尔滨医科大学附属第二医院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p>除了单核/巨噬细胞有重要的致动脉粥样硬化 (AS) 作用外, T细胞在AS中也起着重要作用。辅助性T细胞1型 (Th1) 通过强烈的致凋亡作用影响AS, 其他T细胞亚群如Th2和Th17也参与AS的发生发展。调节性T细胞 (Tregs) 还与Th2相关细胞因子相互作用抑制AS发展。然而现在对T细胞在AS中的具体作用机制尚不明确。本文就T细胞在AS中的作用及这些细胞可能为AS研究和治疗提供的方向作一综述。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%8A%A8%E8%84%89%E7%B2%A5%E6%A0%B7%E7%A1%AC%E5%8C%96&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">动脉粥样硬化;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=T%E6%B7%8B%E5%B7%B4%E7%BB%86%E8%83%9E&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">T淋巴细胞;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=T%E6%B7%8B%E5%B7%B4%E7%BB%86%E8%83%9E%E4%BA%9A%E7%BE%A4&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">T淋巴细胞亚群;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *孙勇, E-mail:ssunyyong@126.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2017-12-13</p>

                    <p>

                            <b>基金：</b>
                                                        <span>国家自然科学基金 (81771946、81670373);</span>
                    </p>
            </div>
                    <h1>Research progress of T lymphocyte in atherosclerosis</h1>
                    <h2>
                    <span>ZHANG Sheng-nan</span>
                    <span>WANG Mei-qi</span>
                    <span>WU Jian</span>
                    <span>YU Bo</span>
                    <span>SUN Yong</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Second Affiliated Hospital of Harbin Medical University</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p>T cells play an important role in atherosclerosis (AS) besides monocytes and macrophages. The T helper cell type 1 (Th1) affect AS via strong apoptotic effect, other T cell subgroups are also involved in occurrence and development of AS, such as Th2 and Th17. The interaction between regulatory T cells (Tregs) and Th2 related cytokines can inhibit AS development. However, mechanism of T cells in AS is still not clear. The present article made a review on role of T cells in AS and their possible guidance for research and treatment of AS.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Atherosclerosis&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Atherosclerosis;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=T-Lymphocytes&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">T-Lymphocytes;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=T-Lymphocyte%20subsets&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">T-Lymphocyte subsets;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    SUN Yong, E-mail: ssunyyong@126.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2017-12-13</p>
                                    <p>
                            <b>Fund：</b>
                                                        <span>National Natural Science Foundation (81771946, 81670373);</span>
                    </p>
            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="3">动脉粥样硬化 (AS) 最初被认为是由胆固醇沉积在动脉壁引起的疾病。然而现在研究发现, AS斑块的形成不是脂质的被动聚集, 而是影响AS的免疫细胞和血管内皮细胞之间的活性作用所导致的<citation id="128" type="reference"><link href="56" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。免疫细胞和血管内皮细胞之间的相互作用干扰了体内自我维持的炎症循环, 形成了促进AS斑块生长和破裂的慢性炎症环境<citation id="129" type="reference"><link href="56" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。通过一系列动物模型和患者的研究发现, 先天性和适应性免疫细胞都对AS的发生和发展有显著影响<citation id="130" type="reference"><link href="58" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。Th细胞是动脉粥样硬化斑块中的主要适应性效应细胞。T淋巴细胞是最早进入AS斑块的细胞之一<citation id="131" type="reference"><link href="60" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。针对于细胞因子的局部环境, T淋巴细胞分化成辅助性T细胞 (Th) 1, Th2或Th17细胞。然而现在关于这些免疫细胞在AS中的作用尚不明确, 故探索新的针对性的方法来指导AS治疗是必要的。本综述将总结其中关于T淋巴细胞在AS中的作用的最新进展, 及这些淋巴细胞为AS的治疗可能提供的突破。</p>
                </div>
                <h3 id="4" name="4" class="anchor-tag"><b>1</b> Th<b>1细胞与</b>AS</h3>
                <div class="p1">
                    <p id="5">Th1细胞分泌促炎性细胞因子如干扰素 (IFN) -γ、白介素 (IL) -12等, 促进单核细胞浸润, 增强巨噬细胞活化, 并调节泡沫细胞的形成。 IFN-γ还与斑块<citation id="132" type="reference"><link href="62" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>中产生的IL-12协同诱导Th1细胞分化。在人AS斑块中, Th1细胞免疫应答占优势, 从人AS斑块分离的T细胞检测出大量Th1表型<citation id="133" type="reference"><link href="64" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="6">在动物实验中已经显示出Th1细胞的促AS作用。IFN-γ缺陷小鼠<citation id="134" type="reference"><link href="66" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>和TH1转录因子T-bet缺陷小鼠<citation id="135" type="reference"><link href="68" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>中显示出延缓AS发展的作用。此外, IFN-γ可以抑制血管平滑肌细胞增殖, 并减少这些细胞的胶原产生, 同时上调基质金属蛋白酶 ( Matrix metalloproteinase, MMPs) 的表达, 从而促进纤维帽的变薄<citation id="136" type="reference"><link href="70" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>, 可能使斑块更容易破裂。与稳定性斑块相比, IFN-γ表达水平在不稳定性斑块中明显升高。在人AS病变外周血中, 刺激IFN-γ产生的IL-18在冠状动脉疾病患者的血浆中升高, 是稳定和不稳定心绞痛中心血管死亡的强烈预测因素<citation id="137" type="reference"><link href="72" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。此外, 促进Th1发育的CD40-CD40L相互作用参与AS。正常动脉组织不含CD40L, 但人AS斑块破裂局部显示内皮细胞、平滑肌细胞和巨噬细胞上免疫反应性CD40L的表达显著升高, 表明CD40-CD40L相互作用在AS中的潜在作用<citation id="138" type="reference"><link href="74" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。总的来说, 这些数据提供了有力的论据表明Th1途径的致AS作用。</p>
                </div>
                <h3 id="7" name="7" class="anchor-tag"><b>2</b> Th<b>2细胞与</b>AS</h3>
                <div class="p1">
                    <p id="8">Th2细胞在AS斑块中所占的比例较少。在Apoe<sup>-</sup>/<sup>-</sup>小鼠中, 严重的高脂血症可以使T细胞转化为Th2表型<citation id="139" type="reference"><link href="76" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>。已经使用各种基因敲除小鼠来评估个体Th2及相关细胞因子在AS中的作用;Th2细胞分泌IL-4、IL-5、IL-10和IL-13, 并且还具有激活B细胞以产生抗体的能力。最初提出Th2反应是通过Th1反应抑制来进行AS保护。然而, Th2途径在AS发展中的作用仍然存在争议, 这取决于病变的阶段和/或部位、Th2分泌因子的类型和实验模型的不同。大多数研究表明IL-4具有促进AS进展作用<citation id="140" type="reference"><link href="78" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>, 而IL-5、IL-13和IL-33可能限制疾病发展<citation id="141" type="reference"><link href="80" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。IL-5的保护作用可能是通过刺激B1细胞产生天然抗体来介导的。实验研究证实IL-5基因座中的单核苷酸多态性与人类冠心病相关<citation id="142" type="reference"><link href="82" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>。特异性LDL亚型诱导的IL-5 (丙二醛-LDL) 激活B1细胞的免疫球蛋白M (IgM) 产生, 这对AS具有保护作用。然而, 缺乏血清IgM的小鼠显示加速AS的形成和进展<citation id="143" type="reference"><link href="84" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。此外, 血浆IL-5浓度与亚临床AS呈负相关<citation id="144" type="reference"><link href="86" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>, IL-5浓度升高与不稳定型心绞痛和心肌梗死以及复发性冠状动脉疾病事件相关。然而, 也有研究表明血浆IL-5与颈动脉内膜中层厚度之间的关系较弱<citation id="145" type="reference"><link href="80" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="9">针对重要的M2型巨噬细胞细胞因子IL-13的研究得出M2型巨噬细胞可能抑制AS进展的结论<citation id="146" type="reference"><link href="88" rel="bibliography" /><sup>[<a class="sup">17</a>]</sup></citation>, 但是这种结论是有争议的, 因为经典的M2诱导剂IL-4促进AS。另外Th2细胞因子IL-33通过诱导IL-5和产生IgM型抗oxLDL抗体部分表现出抗AS作用<citation id="147" type="reference"><link href="90" rel="bibliography" /><sup>[<a class="sup">18</a>]</sup></citation>。总而言之, Th2型细胞因子具有复杂的功能, 部分与AS相反。Th2细胞在人AS斑块中不常见, 其重要性尚不清楚, 其对人类心血管疾病的贡献仍有待于进一步研究。</p>
                </div>
                <h3 id="10" name="10" class="anchor-tag"><b>3</b> Th<b>17细胞与</b>AS</h3>
                <div class="p1">
                    <p id="11">促AS条件和oxLDL可能诱导Th17细胞分化<citation id="148" type="reference"><link href="92" rel="bibliography" /><sup>[<a class="sup">19</a>]</sup></citation>。这些细胞构成斑块中的小群体, 其特征性细胞因子IL-17A也由其他细胞如肥大细胞和嗜中性粒细胞产生<citation id="149" type="reference"><link href="94" rel="bibliography" /><sup>[<a class="sup">20</a>]</sup></citation>。已经报道了Th17细胞对AS发展的不一致的影响。在Apoe<sup>-</sup>/<sup>-</sup>小鼠中, IL-17A缺乏显示出增加<citation id="150" type="reference"><link href="96" rel="bibliography" /><sup>[<a class="sup">21</a>]</sup></citation>、减少<citation id="151" type="reference"><link href="98" rel="bibliography" /><sup>[<a class="sup">22</a>]</sup></citation>、或对AS病变大小没有影响<citation id="152" type="reference"><link href="100" rel="bibliography" /><sup>[<a class="sup">23</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="12">Th17细胞在AS小鼠模型中的作用研究广泛, 已被证明具有促进AS作用<citation id="153" type="reference"><link href="102" rel="bibliography" /><sup>[<a class="sup">24</a>]</sup></citation>。对于使用IL-17A<sup>-</sup>/<sup>-</sup>小鼠, IL-17A阻断抗体, IL-17A重组蛋白或用于下调或上调IL-17A信号传导的任何其他方法的模型, 均证实其促进AS的作用<citation id="154" type="reference"><link href="104" rel="bibliography" /><sup>[<a class="sup">25</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="13">AS斑块组成和其他实验研究指出IL-17A对斑块的稳定作用<citation id="155" type="reference"><link href="106" rel="bibliography" /><sup>[<a class="sup">26</a>]</sup></citation>。对于急性冠脉综合征, 血清中Th17细胞和IL-17A比例升高。此外, 在急性冠脉综合征患者中, 血清IL-17A水平低的患者复发心血管事件的风险增加<citation id="156" type="reference"><link href="108" rel="bibliography" /><sup>[<a class="sup">27</a>]</sup></citation>。事实上, IL-17A已显示会刺激血管平滑肌细胞的胶原合成<citation id="157" type="reference"><link href="110" rel="bibliography" /><sup>[<a class="sup">28</a>]</sup></citation>。总之, 这些研究结果表明Th17细胞随AS疾病的发展而分化, 促进斑块稳定性并且在预防心血管事件中起作用。</p>
                </div>
                <h3 id="14" name="14" class="anchor-tag"><b>4</b> Treg<b>细胞与</b>AS</h3>
                <div class="p1">
                    <p id="15">叉头蛋白3 (FOXP3) <sup>+</sup>Treg细胞存在于人类AS斑块的各个阶段<citation id="158" type="reference"><link href="112" rel="bibliography" /><sup>[<a class="sup">29</a>]</sup></citation>。在AS发生发展的不同阶段, 病变中的T调节细胞 (Treg) 数量和作用不同<citation id="159" type="reference"><link href="114" rel="bibliography" /><sup>[<a class="sup">30</a>]</sup></citation>, 但这些细胞在控制自身反应性T细胞克隆和疾病进展中起重要作用。 Treg细胞的消耗增加了高胆固醇血症小鼠的AS发生<citation id="160" type="reference"><link href="116" rel="bibliography" /><sup>[<a class="sup">31</a>]</sup></citation>, 但Treg细胞的转移具有抗AS的作用。类似地, 实验中扩增Treg细胞群会减小AS的面积<citation id="161" type="reference"><link href="118" rel="bibliography" /><sup>[<a class="sup">32</a>]</sup></citation>、诱导AS消退<citation id="162" type="reference"><link href="120" rel="bibliography" /><sup>[<a class="sup">33</a>]</sup></citation>, 并增加小鼠的斑块稳定性。此外, Wigren M等在实验疫苗研究中表明抗原特异性Treg细胞在AS形成过程中具有重要的保护作用<citation id="163" type="reference"><link href="122" rel="bibliography" /><sup>[<a class="sup">34</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="16">研究报道了Treg细胞相关抗炎性细胞因子IL-10在预防AS发生过程中的具有重要作用<citation id="164" type="reference"><link href="124" rel="bibliography" /><sup>[<a class="sup">35</a>]</sup></citation>。另一种Treg细胞相关的细胞转化生长因子 (TGF) -β也具有多种调节作用。TGF-β的活性受转录后和翻译后修饰调节。TGF-β能够促进Treg分化、耐受和增殖, 在Apoe<sup>-</sup>/<sup>-</sup>小鼠中, T细胞中TGF-β信号途径的破坏导致大量炎性病变<citation id="165" type="reference"><link href="126" rel="bibliography" /><sup>[<a class="sup">36</a>]</sup></citation>。尽管如此, 所有研究表明TGF-β刺激胶原蛋白产生从而稳定斑块。</p>
                </div>
                <h3 id="17" name="17" class="anchor-tag"><b>5 展 望</b></h3>
                <div class="p1">
                    <p id="18">预防心血管疾病需要采取新的策略, 包括降低心血管炎症的药物。由于AS斑块的复杂性和免疫细胞之间发生的动态相互作用, 从免疫上寻找治疗手段是具有挑战性的。需要更好地了解免疫细胞如何在AS中发挥作用, 及其对AS的影响。同时更好地认识AS需要体内实验新模型和方法的建立以及更加全面的分析方法。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="56">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES3CD895DED957AD96C9F281DD8E906BFA&amp;v=MTQ0MTVtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4THU0d0tBPU5pZk9mYkRMYXRuRnF2c3dFT0lLQ3cxTnhoQmc0MGwvUUg2VzJCcEFjTEtTTjh6dUNPTnZGU2lXV3I3SklGcA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>Ren HY, Khera A, de Lemos JA, et al.Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population[J].Am Heart J, 2017, 191:55-61.
                            </a>
                        </p>
                        <p id="58">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13080100041009&amp;v=Mjk4NTE9TmlmT2ZiSzdIdG5Ncm85RlpPOE9ESHd3b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFobw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>Libby P, Lichtman AH, Hansson GK.Immune effector mechanisms implicated in atherosclerosis:from mice to humans[J].Immunity, 2013, 38 (6) :1092-1104.
                            </a>
                        </p>
                        <p id="60">
                            <a id="bibliography_3" target="_blank" href="http://scholar.cnki.net/result.aspx?q=The immunology of atherosclerosis">

                                <b>[3]</b>GisterA, Hansson GK.The immunology of atherosclerosis[J].Nat Rev Nephrol, 2017, 13 (6) :368-380.
                            </a>
                        </p>
                        <p id="62">
                            <a id="bibliography_4" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Inflammation in atherosclerosis">

                                <b>[4]</b>Taleb S.Inflammation in atherosclerosis[J].Arch Cardiovasc Dis, 2016, 109 (12) :708-715.
                            </a>
                        </p>
                        <p id="64">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES4430C9E8D488B13CE014ED7A20F5AAB5&amp;v=MjYxNjJ2bDNSQTFEN2ZsTk1pYUNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMdTR3S0E9TmlmT2ZiZThIZEcvcHZwTkVPOEhCQTQ0ekdWbTZqNTVQUQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>Li Y, Liu X, Duan W, et al.Batf3-dependent CD8α+Dendritic Cells Aggravates Atherosclerosis via Th1 Cell Induction and Enhanced CCL5Expression in Plaque Macrophages[J].EBio Med, 2017, 18:188-198.
                            </a>
                        </p>
                        <p id="66">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Leucine supplementation via drinking water reduces atherosclerotic lesions in apo E nullmice">

                                <b>[6]</b>Zhao Y, Dai XY, Zhou Z, et al.Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice[J].Acta Pharmacol Sin, 2016, 37 (2) :196-203.
                            </a>
                        </p>
                        <p id="68">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+and type 1 regulatory T cells and inhibits early atherosclerosis">

                                <b>[7]</b>Zhong Y, Tang H, Wang X, et al.Intranasal immunization with heat shock protein 60induces CD4 (+) CD25 (+) GARP (+) and type 1regulatory T cells and inhibits early atherosclerosis[J].Clin Exp Immunol, 2016, 183 (3) :452-468.
                            </a>
                        </p>
                        <p id="70">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJRS&amp;filename=SJRS8885904F7BC70082CFF04CF63CEF7232&amp;v=MjA5NzB1NHdLQT1OaWZaZmJ1d0Z0VEZyNHN6WTVsOEMzdzV4eFJnbkVsOVRBeVVxaEZHRE1TVFI3bWRDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4TA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>Benagiano M, Gerosa M, Romagnoli J, et al.β2Glycoprotein IRecognition Drives Th1 Inflammation in Atheroselerotic Plagues of Patients with Primay Antiphospholipid Syndrome[J].J Immunol, 2017, 198 (7) :2640-2648.
                            </a>
                        </p>
                        <p id="72">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJHD&amp;filename=SJHD14031900000667&amp;v=MjkwNTZDbm8rb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFobz1OaWZEYXJLOEh0TE5wbzlGWk9zUA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>Ji Q, Zeng Q, Huang Y, et al.Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome[J].Mediators Inflamm, 2014, 2014:165742.
                            </a>
                        </p>
                        <p id="74">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100340083&amp;v=MTU4NTlGWis4UERIUTZvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYWhvPU5pZk9mYks3SHRET3JvOQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>Antoniades C, Bakogiannis C, Tousoulis D, et al.TheCD40/CD40ligand system:linking inflammation with atherothrombosis[J].J Am Coll Cardiol, 2009, 54 (8) :669-677.
                            </a>
                        </p>
                        <p id="76">
                            <a id="bibliography_11" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Valsartan Attenuates Atherosclerosis via Upregulating the Th2Immune Response in Prolonged Angiotensin II-Treated ApoE (-/-)Mice">

                                <b>[11]</b>Meng K, Zeng Q, Lu Q, et al.Valsartan Attenuates Atherosclerosis via Upregulating the Th2Immune Response in Prolonged Angiotensin II-Treated ApoE (-/-) Mice[J].Mol Med, 2015, 21:143-153.
                            </a>
                        </p>
                        <p id="78">
                            <a id="bibliography_12" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Interleukin-4 regulates macrophage polarization via the MAPK signaling pathway to protect against atherosclerosis">

                                <b>[12]</b>Zhao XN, Li YN, Wang YT.Interleukin-4regulates macrophage polarization via the MAPK signaling pathway to protect against atherosclerosis[J].Genet Mol Res, 2016, 15 (1) .
                            </a>
                        </p>
                        <p id="80">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14123100002962&amp;v=MDczMzZJRjBUYWhvPU5pZk9mYks4SDlQUHJvOUZaT3NOQlhvN29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>Silveira A, McLeod O, Strawbridge RJ, et al.Plasma IL-5concentration and subclinicalcarotid atherosclerosis[J].Atherosclerosis, 2015, 239 (1) :125-130.
                            </a>
                        </p>
                        <p id="82">
                            <a id="bibliography_14" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Large-scale gene-centric analysis identifies novel variants for coronary artery disease">

                                <b>[14]</b>IBC 50KCAD Consortium.Large-scale gene-centric analysis identifies novel variants for coronary artery disease[J].PLoSGenet, 2011, 7 (9) :e1002260.
                            </a>
                        </p>
                        <p id="84">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK9E1FD91CEEF5FB9708824A0059313AC4&amp;v=MDkwMzZDUXBMeGhFVDRqZC9UQTdpckJjOGVyT1hOTW1iQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeEx1NHdLQT1OaWZjWmJyTkg2ZTRwbzQyRVo1NQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>Tsiantoulas D, Bot I, Ozsvar-Kozma M, et al.Increased Plasma IgE Accelerate Atherosclerosis in Secreted IgM Deficiency[J].Circ Res, 2017, 120 (1) :78-84.
                            </a>
                        </p>
                        <p id="86">
                            <a id="bibliography_16" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Anti-interleukin-5and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5levels">

                                <b>[16]</b>Ishigami T, Abe K, Aoki I, et al.Anti-interleukin-5and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5levels[J].FASEB J, 2013, 27 (9) :3437-3445.
                            </a>
                        </p>
                        <p id="88">
                            <a id="bibliography_17" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD121010003256&amp;v=MDY3MjZLNkg5SE5yNDlGWitrS0NoTTh6eFVTbURkOVNIN24zeEU5ZmJ2bktyaWZaZVp2RnludFU3L0xKMTRjTmlmY2Fy&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[17]</b>Cardilo-Reis L, Gruber S, Schreier SM, et al.Interleukin-13protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype[J].EMBO Mol Med, 2012, 4 (10) :1072-1086.
                            </a>
                        </p>
                        <p id="90">
                            <a id="bibliography_18" target="_blank" href="http://scholar.cnki.net/result.aspx?q=IL-33 reduces the development of atherosclerosis">

                                <b>[18]</b>Miller AM, Xu D, Asquith DL, et al.IL-33reduces the development of atherosclerosis[J].J Exp Med, 2008, 205 (2) :339-346.
                            </a>
                        </p>
                        <p id="92">
                            <a id="bibliography_19" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14032300128011&amp;v=MzE1MDlCTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhaG89TmlmT2ZiSzhIdExPckk5Rlpla0hESDA0bw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[19]</b>Lim H, Kim YU, Sun H, et al.Proatherogenic conditions promote autoimmune T helper 17cell responses in vivo[J].Immunity, 2014, 40 (1) :153-165.
                            </a>
                        </p>
                        <p id="94">
                            <a id="bibliography_20" target="_blank" href="http://scholar.cnki.net/result.aspx?q=The role of Th17 cells in the pathogenesis of Behcet&amp;#39;&amp;#39;s disease">

                                <b>[20]</b>Nanke Y, Yago T, Kotake S.The Role of Th17Cells in the Pathogenesis of Behcet's Disease[J].J Clin Med, 2017, 6 (7) .pii:E74.
                            </a>
                        </p>
                        <p id="96">
                            <a id="bibliography_21" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12121700002251&amp;v=MDUxNThmSUlGMFRhaG89TmlmY1piSzZIOVBOcUk5RlpPc05Ebms0b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[21]</b>Danzaki K, Matsui Y, Ikesue M, et al.Interleukin-17Adeficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Biol, 2012, 32 (2) :273-280.
                            </a>
                        </p>
                        <p id="98">
                            <a id="bibliography_22" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011701949455&amp;v=MTIzOTQ4R0NIazhvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYWhvPU5pZk9mYks3SHRETnFJOUViZQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[22]</b>Usui F, Kimura H, Ohshiro T, et al.Interleukin-17deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice[J].Biochem Biophys Res Commun, 2012, 420 (1) :72-77.
                            </a>
                        </p>
                        <p id="100">
                            <a id="bibliography_23" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12121700002011&amp;v=MDU5OTRQTnFJOUZaT3NOREgwNG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhaG89TmlmY1piSzZIOQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[23]</b>Madhur MS, Funt SA, Li L, et al.Role of interleukin 17in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice[J].Arterioscler Thromb Vasc Biol, 2011, 31 (7) :1565-1572.
                            </a>
                        </p>
                        <p id="102">
                            <a id="bibliography_24" target="_blank" href="http://scholar.cnki.net/result.aspx?q=IL-17and Th17cells in atherosclerosis:subtle and contextual roles">

                                <b>[24]</b>Taleb S, Tedgui A, Mallat Z.IL-17and Th17cells in atherosclerosis:subtle and contextual roles[J].Arterioscler Thromb Vasc Biol, 2015, 35 (2) :258-264.
                            </a>
                        </p>
                        <p id="104">
                            <a id="bibliography_25" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SBAD&amp;filename=SBADDC07D90CC860753F328E8CEBE02ABD94&amp;v=MDYyNjNMSHRhNHBvODJGK01KREhzOHpHQVE2RGNJUUF5WDNtYzFlOFBtTWJPYkNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMdTR3S0E9TmkvS2FzZg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[25]</b>Akhavanpoor M, Akhavanpoor H, Gleissner CA, et al.The Two Faces of Interleukin-17A in Atherosclerosis[J].Curr Drug Targets, 2017, 18 (7) :863-873.
                            </a>
                        </p>
                        <p id="106">
                            <a id="bibliography_26" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES3F0D8E345FFB41F05894BCFC850D631D&amp;v=MzA0MjNtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4THU0d0tBPU5pZk9mYkRPSHFYRTJveEJZWjE1Zm5nNHVSWVc0alo1T2d5VTN4b3dlY2FTUnJ2ckNPTnZGU2lXV3I3SklGcA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[26]</b>Ladeiras-Lopes R, Koenig W.Interleukin-17in atherosclerosis:Still a long road ahead[J].Int J Cardiol, 2016, 202:932.
                            </a>
                        </p>
                        <p id="108">
                            <a id="bibliography_27" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Circulating levels of interleukin-17 and car-diovascular outcomes in patients with acute myocardial infarction">

                                <b>[27]</b>Simon T, Taleb S, Danchin N, et al.Circulating levels of interleukin-17and cardiovascular outcomes in patients with acute myocardial infarction[J].Eur Heart J, 2013, 34 (8) :570-577.
                            </a>
                        </p>
                        <p id="110">
                            <a id="bibliography_28" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway">

                                <b>[28]</b>GisterA, Robertson AK, Andersson J, et al.Transforming growth factor-βsignaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway[J].Sci Transl Med, 2013, 5 (196) :196ra100.
                            </a>
                        </p>
                        <p id="112">
                            <a id="bibliography_29" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK062582406F0F1875FB373C964D169D52&amp;v=Mjc2NjFGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMdTR3S0E9TmlmY1piTytITlRFcll0RllwMFBlbjB4eUJObG1EeDZTd3pycWhaQmVMU2RNYitkQ09OdkZTaVdXcjdKSQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[29]</b>Kyaw T, Toh BH, Bobik A.Foxp3+CD4+Regulatory T-Cell Subtypes and Atherosclerosis[J].Circ Res, 2016, 119 (11) :1151-1153.
                            </a>
                        </p>
                        <p id="114">
                            <a id="bibliography_30" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in Apo E-deficient mice">

                                <b>[30]</b>Ji Q, Meng K, Yu K, et al.Exogenous interleukin 37ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice[J].Sci Rep, 2017, 7 (1) :3310.
                            </a>
                        </p>
                        <p id="116">
                            <a id="bibliography_31" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SPQD&amp;filename=SPQD130423021866&amp;v=MzE4OTU4enhVU21EZDlTSDduM3hFOWZidm5LcmlmWmVadkZ5bnRVNy9MSjE0Y05qM2Fhcks3SHRYT3JJOUhaZU1KQ2hN&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[31]</b>Klingenberg R, Gerdes N, Badeau RM, et al.Depletion of FOXP3+regulatory T cells promotes hypercholesterolemia and atherosclerosis[J].J Clin Invest, 2013, 123 (3) :1323-1334.
                            </a>
                        </p>
                        <p id="118">
                            <a id="bibliography_32" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK120927000313&amp;v=MjIyNDQzeEU5ZmJ2bktyaWZaZVp2RnludFU3L0xKMTRjTmlmY1piSzZIdGpPcUk5RlpPZ09EeE04enhVU21EZDlTSDdu&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[32]</b>Dinh TN, Kyaw TS, Kanellakis P, et al.Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibodycomplexes expands CD4+CD25+Foxp3+regulatory T cells and attenuates development and progression of atherosclerosis[J].Circulation, 2012, 126 (10) :1256-1266.
                            </a>
                        </p>
                        <p id="120">
                            <a id="bibliography_33" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice">

                                <b>[33]</b>Kita T, Yamashita T, Sasaki N, et al.Regression of atherosclerosis with anti-CD3antibody via augmenting a regulatory T-cell response in mice[J].Cardiovasc Res, 2014, 102 (1) :107-117.
                            </a>
                        </p>
                        <p id="122">
                            <a id="bibliography_34" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine">

                                <b>[34]</b>Wigren M, Kolbus D, Dunr P, et al.Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine[J].J Intern Med, 2011, 269 (5) :546-556.
                            </a>
                        </p>
                        <p id="124">
                            <a id="bibliography_35" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD0C43B1A2190363AB5543D0E78D774658&amp;v=MjAyMDdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeEx1NHdLQT1OaWZjYXJQTEd0SytydjVIWmVJUEQzbzZ2bVFXN3p0K1BIK1hxeHBCZnJXUVE3K1hDT052RlNpV1dyNw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[35]</b>Huo Y, Chu Y, Guo L, et al.Cortisol is associated with low frequency of interleukin 10-producing B cells in patients with atherosclerosis[J].Cell Biochem Funct, 2017, 35 (3) :178-183.
                            </a>
                        </p>
                        <p id="126">
                            <a id="bibliography_36" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=DYJD201708002&amp;v=MDQ1OTJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WTC9BSVRUQmFyRzRIOWJNcDQ5RlpvUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[36]</b>Tian YL, Wang LJ, Wu Y, et al.Pioglitazone ameliorates atherosclerosis in apoE knockout mice through transforming growth factor-β/Smad signaling and adaptive T cell immunity[J].Nan Fang Yi Ke Da Xue Xue Bao, 2017, 37 (8) :1003-1009.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201902028" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902028&amp;v=MDY2OTZxQnRHRnJDVVI3cWZadVptRnlqbVZML0FQVFhNWmJHNEg5ak1yWTlIYklRS0RIODR2UjRUNmo1NE8zenE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
